Investors/Media

February 9, 2023
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 9, 2023-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that it has
Displaying 11 - 15 of 15